Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$2.61 - $4.49 $136,831 - $235,392
52,426 New
52,426 $148,000
Q2 2023

Aug 14, 2023

BUY
$1.9 - $4.3 $145,443 - $329,160
76,549 New
76,549 $254,000
Q1 2021

May 14, 2021

SELL
$7.33 - $21.06 $162,747 - $467,595
-22,203 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$3.63 - $7.53 $80,596 - $167,188
22,203 New
22,203 $167,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $406M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.